This article aims to address the controversies presented in the literature regarding the role of the HIF-1α subunit in the course of COVID-19, in addition to approaching possible therapies and encouraging the research development related to this important molecule of cellular metabolism. The gene discussed is HIF1A; the disease is COVID-19.